CST3 and chronic kidney disease: In people with CKD, serum cystatin C levels have been shown to be a more reliable predictor of cardiovascular outcomes and risk of progression to end-stage kidney disease (ESKD) than serum creatinine, as well as identifying more people who are at increased risk such as elderly and non-white ethnic groups [13–17].